1. Introduction
In the bygone period, people relied mainly on the plant kingdom for their medicines to cure various health disorders. As per World Health Organization (WHO) statistics, 80% of the world’s population still consumes traditional herbal supplements and medicines [1,2]. Unlike synthetic drugs, medicinal herbs are easily available, especially in low-income countries, and are also generally considered to be non-toxic with fewer side effects. Thus, they are often the preferred treatment option, especially in underdeveloped or other developing countries [2]. With the advent of vertical farming and advancements in biotechnology, there is more scope for these medicinal herb-based systems to get popular in developed countries as well as in the coming years [3]. These medicinal herbs are currently being utilized in pharmaceuticals [4], food preparations [5], nutraceuticals [6], folk medicines [7], and many others due to the biological properties of the bioactive molecules in the plants [8,9].
Terminalia arjuna (TA) is one such folklore medicinal herb, and it belongs to the Combretaceae family. The plant is mainly found in the Indian subcontinent. There are nearly 24 species in India, and it is a deciduous and evergreen tree that grows up to 20–30 m above the ground level. The different parts of the plant, such as the fruit [10], bark [1], leaf [11], seed [12], and root [13] are found to possess different medicinal properties. Among them, barks are found to have rich medicinal value. It is one of the most commonly used plants in Siddha, Ayurveda, and Unani systems of treatment. In India, TA is recognized by different local names such as Arjuna/Arjun (Hindi), Marudhu (Tamil and Malayalam), Yella maddi (Telugu), Arjhan (Bengali), Sadaru (Marathi), Sadad (Gujarati), and Neer matti (Kannada) [9,14,15]. The phytochemicals extracted from TA (Figure 1) are found to have rich antioxidant properties in addition to several other bioactive properties, such as antioxidant [16], anti-inflammatory [[17], cardio-protective [18,19], anti-atherosclerotic [20], and anti-tumor [21]. TA exhibit various pharmaceutical properties when treating various clinical disorders, such as heart failure, ischemia, cardiomyopathy, atherosclerosis, myocardium necrosis, tumor, viral diseases, ulcer and many others [1].This review briefly explains the underlying mechanisms of the above-mentioned properties and their role in various pharmaceutical applications. In addition, this review also focuses on the various types of polymeric formulations to enhance the solubility, bioavailability, and stability of phytochemicals from TA extracts.
The metallic nanomaterials are found to have increased applications in healthcare and environmental applications [22,23]. They are typically synthesized using chemical methods, wherein potent reducing agents are used [24]. Though potent, they are associated with various toxicity issues [24]. Thus, green methods of nanomaterial synthesis are becoming popular [25]. Plant extract-based nanomaterial syntheses are one such method that is found to have low toxicity and more potent medicinal properties with respect to the plant extracts being used. TA-based extracts have been reported in the literature for the syntheses of a wide gamut of nanomaterials. In this review, we also highlight various studies on the green synthesis of metallic nanomaterials using TA-based extracts, the mechanisms behind the syntheses, and their biomedical applications.
2. Extraction of Phytochemicals from TA
Extraction is the initial stage to obtain the bioactive molecules from the desired part of the plant. Medicinal plant extraction has a sequence of steps that begins with the collection and authentication of the plant, then drying, and ends with the extraction, fractionation, and isolation of bioactive molecules. The efficacy of extraction solely depends on the solvents and the process used. The extraction process depends on the solvent’s interaction with the sample to dissolve and diffuse out the desired phytochemicals of interest. The efficiency of the extraction process is mainly based on the particle size of the plant parts, the duration of the extraction process, the temperature, and the solvent to plant mass ratio [26].
The conventional methods of extraction include maceration [27], infusion [28], percolation [29], decoction [30], hot continuous extraction (Soxhlet extraction) [31], and hydro-distillation [32]. The main limitations of traditional extraction methods include their excessive solvent consumption, time-consuming process, low productivity, lack of effectiveness, and inapplicability to all types of components. Modern extraction methods have many advantages, such as being less time-consuming, having high reproducibility, easy automation, and a low utilization of toxic solvents compared to the conventional methods. These methods include supercritical fluid extraction [33], microwave-assisted extraction [34], ultrasound-assisted extraction [35], enzymatic hydrolysis [36], and others [37].
The extraction process of bioactive compounds involves the separation and identification of phytoconstituents, followed by the characterization of extracted plant molecules. Different extraction techniques have different objectives, which range from the selection of the target molecule to the enhancement of selectivity and sensitivity, the conversion of the biomolecules to a suitable form, and above all, to provide a robust and reproducible method to prepare the sample [26].
2.1. Pre-Extraction Process for a TA Plant
The pre-extraction process involves the preparation of the plant materials for the improvement of the efficacy of the extraction process. Moreover, these processes assist in the preservation of phytochemicals prior to extraction.
2.1.1. Drying of TA Plant Materials
Drying is the most important and predominant part of the pre-extraction process [38]. The drying of plant material is usually performed to protect the sample from mold or microbial infestation, tissue deterioration, and phytochemical alterations caused by enzymes or microbes [38]. The drying impacts the quality of the plant material and is usually based on four factors: temperature, humidity, airflow, and the cleanliness of the air. In order to increase the shelf life of the plant material, the ideal moisture content of the plant is reported to be below 12% after drying [38]. The plant materials are typically dried at a temperature below 30 °C, away from the sunlight, with proper air circulation to avoid the degradation of phytoconstituents and to protect the sample from heat and moisture. Likewise, fresh samples are used within 3 h of the collection because the plant materials are susceptible to decomposition if left for longer periods. The field extraction of phytoconstituents with solvents is also reported, but the main limitation of the field extraction is that it will inactivate enzymes in the plant, so alternative methods, such as freezing and preserving in alcohols, are highly preferred [37,39].
2.1.2. Grinding and Powdering of TA Plant Materials
Lowering the particle size increases the surface area for the interaction between the sample and the extraction solvent. To obtain an efficient extraction of the desired phytoconstituents, the solvent must make good contact with the target molecules. Furthermore, the appropriate size of the particles is reported to be smaller than 0.5 mm [37]. The optimum particle size is preferred because it increases the surface area, which will enhance the bulk transfer of active phytochemicals from the plant to the solvent. Hence, the preferred size of particles interact with the solvent and release the phytochemicals, while the larger particles sediment at the bottom and turn slimy during extraction [40]. Traditionally, a mortar and pestle are used to grind the sample. However, in recent times, modern techniques such as the use of a planetary ball miller have been used to grind the sample [37].
2.1.3. Effect of Solvents and the Phytochemicals Polarity on the Extraction Process Efficiency
Solvents are the vital factor in the phytochemical extraction process. They are selected based on the polarity of the molecule and can be classified as polar or non-polar solvents. The polar solvents include water, methanol, ethanol, and others, while the non-polar solvents include hexane, dichloromethane, and others. In the solvent category, water has the highest polarity while hexane has lowest polarity [41]. Table 1 summaries the phytochemicals derived from various parts of TA plant.
TA is a rich source of bioactive molecules and can thus be extracted by both conventional and modern methods. The therapeutic efficacy is based on the extraction method and choice of the solvent. The yield of phytoconstituents is based on the menstruum used. The polar and non-polar solvents are used in the extraction process in the order of increasing polarity [41,65].
The highly polar polyphenols that are extracted using water are the key bioactive molecules of TA. Hence, the aqueous extract of TA has 44% by weight of polyphenols, which are polymeric in nature. The non-polar polyphenols, catechins, and flavonols are isolated by sequential extraction with the use of methyl isobutyl ketone and ethyl acetate. Likewise, n-butanol extracts the mid-polar polyphenols. The catechins, gallocatechins, and ellagic acid are extracted using methanol [42,66].
Triterpenoids are usually non-polar compounds, but their polarity is increased when they react with oxygenated substituents, such as hydroxyl and carboxyl groups (methanol-ethyl acetate) [67]. So far, to extract triterpenes, solvents such as chloroform, dichloromethane, methanol, etc. are utilized [68,69,70].
In TA, tannins belong to the polyphenolic group, which are complex secondary metabolites and are extracted using both polar and non-polar solvents. For instance, the difference in the percentage of tannins obtained from the aqueous and alcoholic extracts of the bark was found to be 16% and 12%, respectively (26,37,39,40).
Thus, obtained extracts are used to treat various biomedical problems, such as heart failure, ischemia, cardiomyopathy, atherosclerosis, myocardium necrosis, blood diseases, anaemia, venereal, fractures, ulcer, and viral disease. The plant is renowned for its cardio-protective properties. This review aims to describe the mechanism of action of the anti-inflammatory, antioxidant, cardioprotective, anti-atherosclerotic, and anti-tumor properties of TA.
3. Mechanism of Action
3.1. Antioxidant
Free radicals are molecular species that donate or accept electrons from other molecules and thus act as oxidants or reductants. These free radicals are unstable and highly reactive (hydroxyl radical, superoxide anion radical, hydrogen peroxide, oxygen singlet, nitric oxide radical, hypochlorite, and peroxynitrite radical), resulting in the damage to cells as well as the disruption of homeostasis. In the human body, free radicals are generated as a result of a few essential metabolic processes, such as exercise and ischemia/reperfusion injury, or due to exposure to harmful radiation sources (such as x-rays, UV, and others) and toxic chemicals (such as cigarette smoke or ozone fumes, to name a few) [71].
Antioxidants are the chemicals that counteract and stabilize the excessive production of free radicals and enhance the immune response. These are generally produced inside the body, or they can be given as a supplement to prevent diseases [71]. Natural herbs are considered to be a rich source of these antioxidants. The phytochemical constituents that are mainly responsible for the antioxidant property are the phenolic compounds [72].
The major flavonoid and phenolic compounds in the leaves of TA include gallic acid, apigenin, luteolin, quercetin, epicatechin, ellagic acid, and 1-O-β-galloyl glucose, and they are identified as the sources for TAs antioxidant activity [47]. Plant biomolecules act as electron donors, reductants, singlet oxygen quenchers, and chelate metal ions to exhibit their antioxidant property [43]. The mechanism behind phenolic compounds’ exhibiting the antioxidant property is that phenolic compounds in plants possess one or more aromatic groups along with one or more hydroxyl groups. The antioxidant potential of the phenolic compounds is due to the conjugation and side chains of the aromatic rings with the generated free hydroxyl radicals. The another antioxidant mechanism in which flavonoids exerts its property is through scavenging the hydrogen peroxide radicals [16]. For instance, hydrogen peroxide is mainly formed by superoxide dismutase within the cells. The flavonoids donate electrons or protons to convert the produced hydrogen peroxide into water. The equation below in Figure 2 represents the possible mechanism of hydrogen peroxide radical scavenging activity of the quercetin (flavonoid) molecule [73].
The role of solvents plays a key role in extracting the right phytochemicals with antioxidant properties. For instance, in the case of phytochemical extraction from TA leaves, the aqueous extraction was found to have the highest free radical scavenging properties when compared to other extraction processes involving other solvents, such as benzene, acetone, petroleum ether, hexane, and chloroform [74,75]. The chloroform extracts non-polar compounds, such as triterpenes and lipids, and the n-butanol extracts mid-polar compounds, such as oxidized catechins and flavanol glycosides, while highly polar compounds, such as tannins and polyphenols, reside in water [42].
Likewise, the methanolic extract of TA bark also exhibits high antioxidant potential, which is mainly due to its flavonoid content [43]. Methanol and ethanol are the solvents generally preferred to extract molecules with antioxidant properties. However, ethanol is highly preferred due to its low levels of toxicity. The polarity and increased solubility of many antioxidant molecules in methanol make it an ideal solvent chemically, although its toxicity limits its applications. With an increase in the concentration of the extract, there is an increase in the reducing power, which is a key indicator in determining the antioxidant activity [72]. Scavenging of hydrogen peroxide (H2O2) is important because it gives hydroxy radicals to cells, which are toxic to cells. It can be neutralized by elevating the dosage level of phytochemical extracts. The phenolic compounds will scavenge the hydrogen peroxide by donating one electron and neutralizing it, leading to the formation of water. The methanolic extract exhibits the highest antioxidant activity, followed by ethanolic extracts, while the lowest activity was found in the n-hexane solvent [64].
3.2. Anti-Inflammatory
Inflammation is usually caused by infection, xenobiotics, and a weak immune response. The inflammatory response involves the recruitment of macrophages and neutrophils in the initial phase, which secrete different mediators to cause acute inflammation. Nitric oxide is a key mediator that induces inflammation through the expression of inducible (iNOS). Plant flavonoids inhibit nitric oxide (NO) production and downregulate the expression of iNOS (nitric oxide synthase). Flavonoids also inhibit the biosynthesis of prostaglandins by inhibiting the enzymes cyclo-oxygenase and COX-1 and 2 at the molecular level. The pro-inflammatory cytokines are also inhibited by these flavonoids [76].
The anti-inflammatory study on the TA leaf was reported for its methanolic extract. The methanolic extract of the leaf efficiently reduced the carrageenan-induced paw edema. The possible mechanism reported was the inhibition of COX enzymes, which leads to the inhibition of prostaglandin synthesis, as depicted in Figure 3 [17].
The commercially available TA capsules (containing TA bark extract) were also studied for their anti-inflammatory activity in paw edema models developed using formalin and carrageenan. It was reported that the plausible anti-inflammatory mechanism could be any of the following: (1) blocking the biosynthesis of proinflammatory mediators (COX II); (2) inhibiting the release of mediators (e.g., histamine, a potent inflammatory mediator); (3) blocking the mediator-receptor (e.g., leukotriene receptor, an inflammatory mediator) interactions; and (4) immune stimulation (e.g., myeloid cell maturation). It was also reported that the TA extract increased the amount of antioxidant enzymes (superoxide dismutase and catalase) as well as reduced the glutathione content, which as a whole results in the enhancement of anti-inflammatory activity [77,78]. For instance, during inflammation, the neutrophils are recruited at the site to initiate the release of ROS and chemokines. The release of superoxide anions activated the endothelial cells, generated chemotactic mediators (leukotriene B4), and upregulated adhesion molecules that increase neutrophil infiltration. The neutrophils under oxidative stress generate reactive oxygen species, where the antioxidant enzyme SOD acts as an endogenous cellular defense system and degrades the superoxide into oxygen and hydrogen peroxide, where the generation of hydrogen peroxide activates the caspases three, eight, and nine, to induce neutrophil apoptosis [79].
3.3. Cardio Protective Property
TA has always been considered a cardio tonic plant since the ancient era and is currently gaining importance in the treatment of various cardiac disorders. The alcoholic extract of TA includes lactones, flavonoids, phytosterol, phenolic compounds, glycosides, and tannins that have excellent antioxidant, antihyperlipidemic, and cardio protective properties [80]. The cardiovascular disease is caused due to many factors, such as hyperlipidaemia, hyperglycaemia, inflammatory response, coagulation factors, increased platelet activation, smoking, and oxidative stress [81].
The cardio-protection is studied using the gemmomodified (plants at growing stage) extract and the methanolic extract of the TA bark. The HPLC analysis of the extracts revealed that bark has a higher concentration of flavonols (quercetin, myricetin, and kaempferol), flavanole (catechin), and phenolic acid (gallic acid, P. coumaric, and ferulic acid). The mechanisms behind TAs cardiac protection properties are as follows: 1. Flavonoids present in them reverse endothelial dysfunction and reduce the arterial pressure by increasing the vasorelaxation process. 2. The flavonoids also scavenge the free radical species through scavenger receptors and help in the uptake and elimination of oxidized modified low-density lipoprotein (OM-LDL)(OM-LDL is a chemically modified LDL that results in endothelial injury to initiate atherosclerotic plaque formation [82]). 3. Regulation of platelet activity and by inhibition of platelet aggregation as depicted in Figure 4. Both the bark extract as well as the gemmomodified extract have potent properties to cure induced myocardial infarction [61].
The aqueous ethanolic extract of bark has been studied for various factors that cause chronic heart failure. For instance, lipids play a vital role in cardiovascular diseases since the alteration in lipid metabolism manipulates cardiac functions by affecting the structure, stability, and composition of the cell membrane, which in turn leads to cell death followed by ischemia. This extract helps by reducing the LDL and increasing the HDL, which proves the lipid-lowering properties of the plant extract. In other instances, the cell membrane of the myocardial cells gets damaged, which results in the leakage of the enzyme, creatine kinase. The treatment with aqueous ethanolic extract maintains the membrane’s integrity by increasing the level of creatine kinase and thereby stopping the leakage of enzymes [83]. Another study revealed that the cardio-protection properties of TA are due to the following reasons: (a) through the antioxidant properties of tannins and (b) through activating the physiological antioxidants inside the body by the oleanane triterpenoids [84].
3.4. Anti–Atherosclerotic
Atherosclerosis is an inflammatory vascular disease caused by the deposition of cholesterol in the arterial wall. Atherosclerosis is one of the major causes of cardiovascular diseases. The key factors responsible for plaque formation are the stimulation and differentiation of monocytes in the blood stream, followed by the low-density lipoprotein uptake by macrophages to form the foam cells [85]. The different ethanolic derivatives of TA demonstrate the presence of phenolics, tannins, triterpenoids, saponins, anthraquinone glycosides, alkaloids, and flavonoids and confirm the anti-hyperlipidemic activity through its anion exchange property. The main mechanism behind the anion exchange property is that the anions of phytochemicals in the plant bind with the bile acid anions in the intestine and convert cholesterol into bile acid, which is then excreted in stool and leads to a decrease in the serum LDL cholesterol level [86]. Arjunic acid and Arjunoglycoside (I, II, III and IV) undergo a drug-metabolizing cascade, produce some active molecules, and are responsible for lipid-lowering activity [20]. Tannins also are found to be helpful in depleting the lipid activity [87].
There is another mechanism reported that uses the aqueous bark extract of TA to treat atherosclerosis. The medicinal herbs are rich sources of ligands for nuclear receptors, such as the peroxisome proliferator-activated receptor α (PPARα) and the peroxisome proliferator-activated receptor γ (PPAR γ). Figure 5 provides a schematic representation of the mechanism of TA to inhibit NF-κβ and thus prevent plaque progression. Treatment with this extract activates the PPAR-γ by inhibiting the NF-κβ, which reduces the action of Interleukin 18 (IL 18) and also inhibiting the expression of other cytokines, chemokines, and adhesion molecules, and finally stops the plaque progression. Additionally, the TA extract also soothes the inflammatory cascade through pleiotropic activation of PPAR–γ and LXR (liver X receptors)–α as PPAR–γ upregulates the LXR–α and promotes cholesterol efflux and it also regulates the scavenger receptor (CD36) activation which helps in uptake of oxidized LDL in foam formation. The reduced expression of matrix metallopeptidase 9 (MMP 9) is also another possible mechanism to reduce atherosclerotic plaque formation [88].
3.5. Anticancer
Cancer is a life-threatening disease that often results in death. The current treatment strategies include primarily surgery, radiotherapy, and chemotherapy, with few adjuvant therapies. The above-mentioned treatment strategies are very harsh on patients, resulting in pain and serious side-effects, such as the loss of hair and severe pain, to name a few. In order to reduce the side-effects of the existing cancer treatment strategies, herbal medicines are currently much preferred. These phytoconstituents are reported to have excellent properties, such as (a) methyltransferase inhibition, (b) DNA damage prevention or antioxidant properties, (c) histone deacetylases inhibition, and (d) mitotic disruption that prevents cancer development.
The secondary metabolites, such as polyphenols, brassinosteroids, and taxol, are found to possess anti-cancer activity [89]. In TA, the high content of tannin and polyphenols is mainly responsible for the anticancer activity [90]. Besides the phytoconstituents, the taxol is also produced from Pestalotiopsis terminaliae, an endophytic fungus found in the leaves of TA. Taxol is a highly preferred drug for the treatment of human malignant cancers. In cancer cells, microtubule formation plays a major role in mitosis, motility, cell shape, and cellular response. The microtubule is comprised of α and β tubulin heterodimers which helps in the assembly of microtubule network through polymerization. The α and β tubulin are the globular proteins with three functional domains (N-terminal, C-terminal, and an intermediate domain). Taxol binds with the β-tubulin on the intermediate domain to suppress the spindle formation and deploy the mitotic division, thereby arresting the cell division of the malignant cells [90,91,92]. TA extracts are also tested in colon and liver cancer cell lines for their anti-cancer activity. It was found that the bioactive molecules in the TA leaf extract destroy the cancer cells either by activating apoptosis or through the inhibition of the growth regulators [93]. The anticancer activity of TA bark is reported to be due to the presence of phenolic compounds that interact with target DNA through signaling pathways, as depicted in Figure 6, and block the sites involved in the electrophilic attack by reactive carcinogenic moieties [21].
4. Green Synthesis of Nanoparticles Using TA Extracts
Nanotechnology is an emerging and interesting multidisciplinary field of science that deals with particles/materials of a dimension of 1–100 nm [94]. Metallic nanoparticles have many unique properties, such as a high surface area, high surface energy, and quantum confinement when compared to their bulk counterparts [95]. There are three most commonly used methods of metal nanoparticle synthesis: physical (ball milling [96], plasma arcing [97], spray pyrolysis [98], sputter deposition [99], etc.), chemical (electrodeposition [100], sol-gel process [101], co-precipitation method [102], etc.), and biological methods (using plants, algae, and microorganisms). Among the three different methods of nanoparticle synthesis, biological methods are gaining popularity due to their sustainable and green approach, mostly with one-step methods of bio-reduction with less energy consumption and an eco-friendly approach [103]. On the other hand, the physical and chemical methods suffer from some issues, such as being highly energy intensive, utilizing radiation, and requiring a high solvent consumption, which are harmful for human health [95].
In biological methods, various sources such as algae [104], microorganisms [105], and plants [10] are considered efficient and eco-friendly green nano-factories that are capable of converting metal ions to metal nanoparticles (Ag, Au, Cu, Pd, Fe, and Zn) that can be utilized in various biological applications [106]. In microbes, the reductase enzyme, microbial proteins, metal resistance genes, and the reduction of co-factors play an important role in the synthesis of nanoparticles. Organisms such as bacteria, yeast, and fungi are the nano-factories that act as reducing and capping agents. Whereas, in phyto-nanotechnology (plant-based nanoparticle synthesis), organic acids, vitamins, proteins, and secondary metabolites such as alkaloids, flavonoids, terpenoids, polysaccharides, and heterocyclic compounds support the synthesis of nanoparticles. The different parts of a plant, such as the bark, root, fruit, oil, leaf, and flower, are all utilized in biological synthesis [94,107]. The size, shape, and composition of nanoparticles depend on the parts and phytoconstituents of the plants [108,109].
TA is used in the synthesis of different metal nanoparticles. Figure 7 depicts the schematic overview of the green synthesis of metallic nanoparticles using TA. This review explains the synthesis of various types of nanoparticles from TA extracts and their biomedical applications. Various parts of TA are used in the synthesis of metallic nanoparticle. Till dates, metallic nanoparticles, such as gold, silver, copper, iron, and palladium, are synthesized using TA extracts. The most common methods employed in the nanoparticles’ syntheses are microwave irradiation [46], boiling [110], hydrothermal [111], sonication [111], stirring [112], wet chemical [111], and shaking [113], which each take place under different conditions.
4.1. Silver Nanoparticles
The synthesis of silver nanoparticles using a plant extract requires vital elements such as a silver metal ion solution and a capping agent. The polyphenols and protein molecules in TA extracts act as capping and reducing agents. The peptides degrade into smaller peptides, whose carboxylate groups help in the stabilization of nanoparticles by forming the corona layer on their surface [114]. In the green synthesis for the reduction of silver ions, a precursor silver nitrate is used along with the plant extract. The size of the nanoparticle can be controlled by environmental factors such as pH, temperature, precursor concentration, extraction time, and extract concentration. The size-controlled silver nanoparticles can be utilized for various biological applications [114].
The major bioactive molecules involved in the phyto-reduction process of silver nanoparticles are alkaloids, terpenoids, flavonoids, ketones, aldehydes, amides, tannins, quinines, and carboxylic acid [114]. Among all the bioactive molecules in TA, polyphenols are the key molecules that are used in the reduction of silver ions to form silver nanoparticles (Ag+ to Ag0). The metallic nanoparticles synthesized by the phenolic compounds have a high stability when compared with other reducing agents, such as citrate or sodium borohydride [106,115]. The natural phenols with hydroxyl and carbonyl groups have protonating and metal absorbing capabilities, while the catechol group of some phenolic compounds has only a metal-absorbing capability. The catechol functional group absorbs the metal surface through three different configurations, including a bidentate bridging bond, a bidentate chelating bond, and a monodentate-ester-like bond (Figure 8A) [46,106,115]. The phytoconstituents are the key molecules that help in mediating the synthesis reaction by performing the dual task of reducing and capping the agent. Further, it also acts as a stabilizer in the post-synthesis process, as illustrated in Figure 8B [116]. In the case of the flavonoids, the keto group helps in reducing silver to silver nanoparticles while converting flavonoids to an enol form [114].
4.2. Gold Nanoparticles
TA extract acts as a reducing agent for the synthesis of gold nanoparticles with the help of a precursor called chloroauric acid (HAuCl4). Molecules such as arjunetin, leucoanthocyanidins, and hydrolysable tannins are reported to be involved in the gold nanoparticle synthesis [117]. Furthermore, the green synthesis has a low cytotoxicity compared to chemical synthesis [118]. The main ingredient of TA that helps in the gold nanoparticle synthesis is polyphenols [119,120]. The polyphenolic compound can also be used for in situ stabilization of gold nanoparticles. The gold nanoparticles are synthesized and stabilized by the following reported mechanism: Au3+ is chelated by the adjacent hydroxyl group of the polyphenolic compound to form a five-membered chelate ring. Thus, the chelated o-dihydroxyl becomes oxidized to quinones and thus helps in the further reduction of Au3+ to Au0. The oxidized quinone stabilizes the gold nanoparticle and prevents aggregation [119]. Table 2 summarizes the metallic nanoparticles synthesized using TA extract and their role in the biomedical application.
5. Polymeric Formulation of TA Extracts
The phytochemicals extracted from TA extracts have several beneficial properties, as mentioned above; however, they suffer from limitations, such as low bioavailability, low stability, and low therapeutic efficacy. In order to overcome the above-said issues, a few polymeric formulations were explored [109,138]. There is one study in the literature where they have investigated the possibility of encapsulating the TA extract inside a few synthetic polymeric materials, such as Poly (lacto-co-glycolic acid) (PLGA), Polycarbonate (PC), Polypropylene (PP), Polyethylene (PE), Polytetrafluoroethylene (PTFE), and Chitosan [139]. However, there are no detailed investigations on the extract release kinetics and other pharmacokinetic studies. Further in-depth investigations are warranted. The below section summarizes a few studies relevant to the encapsulation and prolonged release studies of TA extracts using polymeric biomaterials.
5.1. Transdermal Delivery of TA Extracts
Transdermal delivery is one of the least invasive systems for delivering drugs directly to the blood stream by skipping the first pass metabolism in the liver and also increasing the bioavailability of the TA extract. A TA-extract-loaded chitosan ERL100 transdermal patch has been reported in the literature. Chitosan has good muco-adhesive properties and greater solubility in acidic aqueous solutions. The co-polymer Eudragit RL 100 (ERL 100) (containing acrylic acid and methacrylic acid esters as co-polymers with low quaternary ammonium groups) helps convert the polymer into salt to further enhance the permeability of the polymer. The polymeric patch was developed using the solvent evaporation technique. The designed patch was stable for three months and showed a controlled TA extract release for a prolonged time of up to 12 h with no allergic reactions in albino rats for 72 h [138].
There is another report on the emulgel-based transdermal delivery systems for TA extracts. The methanolic TA extract is emulsified using oil, surfactant, and co-surfactant and is fed into carbopol hydrogel. The in vitro and ex vivo release studies of the extract from the emulgel were conducted, and the maximum and prolonged release were found in 500 mg of the extract. The in vitro maximum release percentage was found to be 91.43% in 720 min and in ex vivo it was found to be 89.32% [140].
5.2. TA Bark Gum as a Biomaterial for Ophthalmic Application
Stimuli-responsive gels are an attractive material of choice for drug delivery in ophthalmic applications. pH-responsive gelling systems are an ideal candidate, as they can be transformed into gels upon a change in pH. In one study, gum from TA bark was combined with sodium alginate (SA) to fabricate an in situ gelling system for the delivery of moxifloxacin HCl (MOX-HCl). The system was found to be a clear solution before injection and was converted into a gel in the presence of tear solution. Furthermore, the gel was found to release the drug in a sustained and controlled manner for twelve hours with no signs of irritation or any other abnormalities such as inflammation or increased tear secretion. Thus, TA bark gum blended with SA in situ gel containing MOX-HCl was reported as an eye-drop replacement for extended precorneal retention, improved corneal permeability, and improved ocular bioavailability [141].
6. Conclusions and Future Perspectives
Terminalia arjuna is a medicinal plant that has several medicinal properties, such as anti-inflammatory, antioxidant, anti-ischemic, anti-atherosclerotic, antimicrobial, anti-cancer, anti-fertility, anti-mutagenic, etc. These properties are due to the presence of a variety of phytochemicals, such as flavonoids, polyphenols, triterpenoids, tannins, glycosides, and several others, in the extracts. The extraction of the desired phytochemicals depends on several factors, such as solvent properties, phytochemical properties, extraction methods, and many others, which are detailed in this review. The synthesis of metallic nanomaterials, especially gold and silver nanoparticles, using TA extracts is elaborated; however, more detailed physicochemical characterizations and mechanistic understandings are warranted. More in-depth in vitro and in vivo studies are needed to understand the advantages of these nanomaterials when compared to their chemically synthesized counterparts.
Although TA plant extracts have several unique and beneficial biomedical properties, as elaborated in this review, their potential is not yet utilized to the fullest. We expect more investigations on various types of formulations, such as nano/micro encapsulation technologies and scaffold- and hydrogel-based encapsulation technologies, to enhance the bioavailability and stability of the TA extracts. Moreover, there is also a need to further investigate detailed mechanisms of action using advanced omics studies to have a system-level view on the efficacy and toxicity of these extracts. Furthermore, there is a need for long-term toxicity studies on these extracts to be convincingly approved by regulatory authorities.
A.P. and P.R. conceptualized the paper; P.R wrote the paper; A.P. reviewed and edited the manuscript. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
All the data and materials that support the results or analyses presented in their paper are freely available upon request.
A.P. and P.S.R. would also like to acknowledge the support received from the Center for Biomaterials, Cellular, and Molecular Theranostics (CBCMT), the School of Biosciences and Technology (SBST), and the Periyar Central Library of Vellore Institute of Technology, Vellore.
The authors declare no conflict of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 2. Mechanism of hydrogen radical scavenging activity of quercetin (flavonoid) present in TA extracts were reproduced with permission [73].
Figure 3. Anti-inflammatory mechanism of action of TA extract on Carrageenan-induced paw edema.
Figure 5. Schematic illustration of plausible mechanism behind the anti-atherosclerotic activity of TA extracts. The red arrow in the figure indicates the upregulation of nuclear receptors (PPAR-γ and LXR-α).
Figure 6. Schematic representation of the mechanisms behind the anticancer activity of TA extracts.
Figure 7. Schematic representation of the various steps involved in the green synthesis of metallic nanoparticles using TA extract.
Figure 8. Schematic illustration of mechanism behind polyphenol in metallic nanoparticle synthesis, (A) catechol binding mechanism with silver nanoparticles, (B) silver nanoparticle synthesis were reproduced with permission [115].
Summary of the phytochemicals derived from various parts of TA plant, their extraction methods, and their biomedical applications.
S. No | Part Used | Extraction Method | Solvent Used | Phytochemicals Derived | Application | Reference |
---|---|---|---|---|---|---|
1. | Bark | Refluxing | Water | Polyphenols | Polyphenol analysis | [ |
Methanol | Catechins |
|||||
2. | Bark | Soxhlet | Methanol | Phytosterol |
Antimicrobial |
[ |
3. | Bark-B |
Shaking incubation | Hexane | Alkaloid–F, L |
Antioxidant |
[ |
Ethyl acetate | Steroids–B, F |
|||||
Chloroform | Steroids-F |
|||||
Acetone | Tannins and phenolics |
|||||
Ethanol | Steroids |
|||||
Methanol | Steroids |
|||||
Distilled water | Tannins and phenolic |
|||||
4. | Bark | Soxhlet | Methanol | Phenols |
Antibacterial |
[ |
Ethanol | Flavonoids |
|||||
Petroleum ether | Phenols |
|||||
n-hexane | Phytosterols |
|||||
Chloroform | Phenols |
|||||
Water | Carbohydrate |
|||||
5. | Bark | Microwave-assisted extraction | Water | Flavonoids |
Antioxidant |
[ |
6. | Bark |
Incubation | Ethanol | Phenolics |
Antioxidant |
[ |
7. | Bark | Ultrasound-assisted extraction | Ethanol | Not mentioned | Antimicrobial | [ |
8. | Bark | Ultrasound-assisted extraction | Chloroform | Not mentioned | Determination of isoquinoline alkaloid |
[ |
9. | Bark | Decoction | Water | Gallic acid |
Cardiotonic property | [ |
10. | Bark | Soxhlet | Methanol | Tannin |
Anthelmintic | [ |
11. | Bark | Decoction | Water | Not mentioned | Ayurvedic formulation | [ |
12. | Bark | Hot continuous percolation-soxhlet | Ethyl alcohol | Not mentioned | Cardioprotective effect | [ |
13. | Bark | Percolation | Ethanolic | Flavonoids |
Hypoglycemic effect | [ |
14. | Bark | Hot continuous percolation-soxhlet | Water | Arjunolic acid |
Catecholamine-induced myocardial fibrosis and oxidative stress | [ |
15. | Bark | Hot continuous percolation | Water | Glycosides |
Pulmonary hypertension | [ |
16. | Bark | Hot percolation | Methanol | Tannins and Phenolic |
Osteogenic activity | [ |
17. | Bark | Cold percolation | Hydroalcoholic | Tannins |
Hypolipidemia activity | [ |
18. | Bark | Hot continuous percolation-soxhlet | Ethyl alcohol | Tannins |
Atherogenic-induced dyslipidemia and metabolic syndrome | [ |
19. | Leaf | Maceration | Phosphate buffered saline | Terpenoids |
Inhibition of T-cell antigen | [ |
20. | Bark | Cold maceration | Ethyl alcohol | Phytosterol |
Antioxidant potential of TA | [ |
21. | Bark | Reflux | Methanol | Gallic acid |
Cardioprotective Potential | [ |
Maceration | Glycerin/Methanol | |||||
22. | Bark | Maceration | Ethanol | Phenolic compounds | Anticancer activity of TA onHuman hepatoma cell (HepG2) | [ |
23. | Bark | Soxhlet | Butanol | Tannins and Phenolics |
Cardioprotective potential in doxorubicin-induced cardiotoxicity | [ |
24. | Leaf | Maceration | Methanol | Alkaloids |
Analgesic and Anti-inflammatory activity | [ |
25. | Bark | Soxhlet | Methanol |
Flavonoids | Antioxidant | [ |
Summary of green synthesized nanoparticles using TA extracts for various biomedical applications.
S. No | Name | Synthesis Method | Extract/Organism Used | Color of Nanoparticles Solution | Average Nanoparticle Size (nm) | Shape of Nanoparticles | Optimal Dosage | Application | Reference |
---|---|---|---|---|---|---|---|---|---|
1. | Silver | Incubation | Aqueous leaf | Yellow to dark brown | 5–20 | Spherical | Nil | Antimicrobial | [ |
2. | Silver | Hot plate magnetic stirring | Aqueous bark | Dark brown | 65 | Spherical | Nil | Antibacterial | [ |
3. | Silver | Shaking incubation | Endophytic bacteria from TA bark | Dark brown | 42.2 | Spherical | Nil | Antimicrobial | [ |
4. | Silver | Incubation | Aqueous fruit, bark, and foliage | Dark brown and intense brown | - | Spherical and irregular shape | Nil | Antimicrobial | [ |
5. | Silver | Incubation | Aqueous bark | Dark brown | 34–70 | Spherical | Nil | Cytotoxicity | [ |
6. | Silver | Microwave irradiation | Aqueous bark | Dark brown | 10–15 | Spherical | Nil | Antioxidant and antimicrobial | [ |
7. | Silver | Incubation | Aqueous bark | Dark brown | Non–uniform | Spherical and arbitrary | Nil | Antibacterial | [ |
8. | Silver | Incubation | Aqueous bark | Dark brown | 20–50 | Spherical | Nil | Larvicidal | [ |
9. | Silver | Microwave irradiation | Aqueous bark | Dark brown | 20–30 | - | Nil | Antimicrobial and anticancer | [ |
10. | Silver | Incubation | Endophytic fungi from TA leaves | Dark brown | 45, 55 | - | Nil | Antifungal | [ |
11. | Silver | Incubation | Aqueous bark | Dark brown | 40–50 | Spherical | Nil | Antibacterial | [ |
12. | Silver | Microwave irradiation | Aqueous and methanolic bark | Dark brown | 20–50 | Spherical | Nil | Antibacterial and antibiofilm | [ |
13. | Gold | Boiling | Aqueous bark | Dark brown | Nil | Nil | 175 µg/kg/day | Nephrotoxicity | [ |
14. | Gold | Incubation at room temperature | Ethanolic arjunolic acid | Dark brown | 185 nm | Spherical | Nil | Entrapment study and release study of gel-gold nanoparticle | [ |
15. | Gold | Boiling | Aqueous bark | Dark brown | 7–20 nm | Spherical | 175 µg/kg/day | Hepatotoxicity | [ |
16. | Gold | Incubation at room temperature | Aqueous leaf | Yellow to dark red | 20–50 nm | Spherical | Nil | Mitotic cell division and pollen germination | [ |
17. | Gold | Drop wise addition | Aqueous bark | Violet to pinkish red | 15–20 nm | Triangular, tetragonal, pentagonal, hexagonal, rod, and spherical | Nil | Catalysis | [ |
18. | Gold | Stirring | Aqueous bark | Pale yellow to ruby red | Nil | Nil | 175 µg/kg/day | Reproductive dysfunction | [ |
19. | Gold | Stirring | Aqueous bark | Pale yellow to ruby red | 20–40 nm | Spherical | 175 µg/kg/day | Hematological alterations | [ |
20. | Gold | Boiling | Aqueous fruit | Yellow to reddish wine | 25 nm | Spherical | Nil | Seed germination activity | [ |
21. | Gold | Incubation | Aqueous leaf | Light yellow to bright red | 15–30 nm | Spherical | Nil | Antibacterial | [ |
22. | Gold | Stirring | Ethanolic bark | Yellow to pink and ruby red | 3–70 nm | Spherical and triangular | 50 µg/mL | Neuroprotective potential | [ |
23. | Copper | Shaking | Aqueous bark | Blue to brown | 10–26 | Spherical | Nil | Antimicrobial | [ |
24. | Copper | Microwave irradiation | Aqueous bark | Pale yellow to dark brown | 23 | Spherical | Nil | Antimicrobial and antioxidant | [ |
25. | Copper | Microwave irradiation | Aqueous bark | Light yellow to black | 20–30 | Nil | Nil | Antimicrobial and anticancer | [ |
26. | Iron | Microwave irradiation | Aqueous bark | Yellow to greenish black | 20–80 nm | Globular | Nil | Photo degradation | [ |
27. | Palladium | Incubation | Aqueous bark | Dark brown | 4–16 | Spherical | Nil | Catalysis | [ |
28. | Zinc | sonication, wet chemical, and hydrothermal | Aqueous bark | Nil | 43, 34, 21 | Spherical | 25 mg mL−1 | Toxicity and antibacterial | [ |
References
1. Amalraj, A.; Gopi, S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review. J. Tradit. Complement. Med.; 2017; 7, pp. 65-78. [DOI: https://dx.doi.org/10.1016/j.jtcme.2016.02.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28053890]
2. Sen, T.; Samanta, S.K. Medicinal Plants, Human Health and Biodiversity: A Broad Review. Biotechnological Applications of Biodiversity; Mukherjee, J. Advances in Biochemical Engineering/Biotechnology Springer: Berlin/Heidelberg, Germany, 2014; Volume 147, pp. 59-110. ISBN 978-3-662-45096-3 Available online: http://link.springer.com/10.1007/10_2014_273 (accessed on 27 July 2021).
3. Demirbaş, N. Vertical Agriculture: A Review of Developments. Proceedings of the IBANESS Congress Series; Tekirdag, Turkey, 5–6 October 2019.
4. Kanthe, P.S.; Patil, B.S.; Das, K.K. Terminalia arjuna supplementation ameliorates high fat diet-induced oxidative stress in nephrotoxic rats. J. Basic Clin. Physiol. Pharmacol.; 2021; 33, pp. 409-417. [DOI: https://dx.doi.org/10.1515/jbcpp-2020-0106] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33743558]
5. Dube, N.; Nimgulkar, C.; Bharatraj, D.K. Validation of therapeutic anti-inflammatory potential of Arjuna Ksheera Paka—A traditional Ayurvedic formulation of Terminalia arjuna. J. Tradit. Complement. Med.; 2017; 7, pp. 414-420. [DOI: https://dx.doi.org/10.1016/j.jtcme.2016.11.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29034188]
6. Hussain, S.A.; Panjagari, N.R.; Singh, R.R.B.; Patil, G.R. Potential Herbs and Herbal Nutraceuticals: Food Applications and Their Interactions with Food Components. Crit. Rev. Food Sci. Nutr.; 2015; 55, pp. 94-122. [DOI: https://dx.doi.org/10.1080/10408398.2011.649148]
7. Peterson, C.T.; Denniston, K.; Chopra, D. Therapeutic Uses of Triphala in Ayurvedic Medicine. J. Altern. Complement. Med.; 2017; 23, pp. 607-614. [DOI: https://dx.doi.org/10.1089/acm.2017.0083]
8. Soni, N.; Singh, V. Efficacy and Advancement of Terminalia arjuna in Indian Herbal Drug Research: A Review. Trends Appl. Sci. Res.; 2019; 14, pp. 233-242. [DOI: https://dx.doi.org/10.3923/tasr.2019.233.242]
9. Ahmed, K.K.M.; Gupta, G.B.M.; Singh, N.; Kumar, A. Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18. Pharmacogn. Rev.; 2021; 14, pp. 45-52. [DOI: https://dx.doi.org/10.5530/phrev.2020.14.8]
10. Gopinath, K.; Gowri, S.; Karthika, V.; Arumugam, A. Green synthesis of gold nanoparticles from fruit extract of Terminalia arjuna, for the enhanced seed germination activity of Gloriosa superba. J. Nanostructure Chem.; 2014; 4, 115. [DOI: https://dx.doi.org/10.1007/s40097-014-0115-0]
11. Desai, D.; Chanda, S. Pharmacognostic Study and Physicochemical Analysis of Leaves of Terminalia arjuna. Pharmacogn. J.; 2014; 6, pp. 15-19. [DOI: https://dx.doi.org/10.5530/pj.2014.6.4]
12. Goswami, M.; Chaturvedi, P.; Kumar Sonwani, R.; Dutta Gupta, A.; Rani Singhania, R.; Shekher Giri, B.; Nath Rai, B.; Singh, H.; Yadav, S.; Sharan Singh, R. Application of Arjuna (Terminalia arjuna) seed biochar in hybrid treatment system for the bioremediation of Congo red dye. Bioresour. Technol.; 2020; 307, 123203. [DOI: https://dx.doi.org/10.1016/j.biortech.2020.123203]
13. Chouksey, B.K.; Srivastava, S.K. New constituent from the roots of Terminalia arjuna: Antifungal agent. NIScPR Online Period. Repos.; 2001; 40, pp. 354-356.
14. Gupta, S.; Bishnoi, J.; Kumar, N.; Kumar, H.; Correspondence, J.; Nidheesh, T. Terminalia arjuna (Roxb.) Wight &Arn.: Competent source of bioactive components in functional food and drugs. Innov. J.; 2018; 7, pp. 223-231.
15. Gaikwad, D.; Jadhav, N. A review on biogenic properties of stem bark of Terminalia arjuna: An update. Asian J. Pharm. Clin. Res.; 2018; 11, pp. 35-39. [DOI: https://dx.doi.org/10.22159/ajpcr.2018.v11i8.26384]
16. Kasote, D.M.; Katyare, S.S.; Hegde, M.V.; Bae, H. Significance of Antioxidant Potential of Plants and its Relevance to Therapeutic Applications. Int. J. Biol. Sci.; 2015; 11, pp. 982-991. [DOI: https://dx.doi.org/10.7150/ijbs.12096]
17. Moulisha, B.; Biswas, K.; Karan, T.; Bhattacharya, S.; Haldar, P. Evaluation of analgesic and anti-inflammatory activities of Terminalia arjuna leaf. J. Phytol.; 2011; 3, pp. 33-38.
18. Krishnamurthy, K.; Rm, S.; Karunakaran, G.; Sathish, K.; Devaraj, N. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci.; 2003; 73, pp. 2727-2739. [DOI: https://dx.doi.org/10.1016/S0024-3205(03)00671-4]
19. Kapoor, D.; Vijayvergiya, R.; Dhawan, V. Terminalia arjuna in Coronary Artery Disease: Ethnopharmacology, Pre-Clinical, Clinical & Safety Evaluation—ScienceDirect. J. Ethnopharmacol.; 2014; 155, pp. 1029-1045.
20. Subramaniam, S. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J. Exp. Biol.; 2011; 7, pp. 282-288.
21. Sarveswaran, S.; Ilayaraja, M.; Balasubramanian, M. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol. Cell. Biochem.; 2006; 281, pp. 87-93. [DOI: https://dx.doi.org/10.1007/s11010-006-0433-8]
22. Augustine, R.; Hasan, A. Emerging applications of biocompatible phytosynthesized metal/metal oxide nanoparticles in healthcare. J. Drug Deliv. Sci. Technol.; 2020; 56, 101516. [DOI: https://dx.doi.org/10.1016/j.jddst.2020.101516]
23. Shrivastava, P.; Jain, V.K.; Nagpal, S. Nanoparticle intervention for heavy metal detection: A review. Environ. Nanotechnol. Monit. Manag.; 2022; 17, 100667. [DOI: https://dx.doi.org/10.1016/j.enmm.2022.100667]
24. Rahimi, H.-R.; Doostmohammadi, M.; Rahimi, H.-R.; Doostmohammadi, M. Nanoparticle Synthesis, Applications, and Toxicity. Applications of Nanobiotechnology; IntechOpen: London, UK, 2019; ISBN 978-1-78985-978-2 Available online: https://www.intechopen.com/chapters/69099 (accessed on 12 November 2022). [DOI: https://dx.doi.org/10.5772/intechopen.87973]
25. Singh, A.; Kaur, K.; Singh, A.; Kaur, K. Biological and Physical Applications of Silver Nanoparticles with Emerging Trends of Green Synthesis. Engineered Nanomaterials-Health and Safety; IntechOpen: London, UK, 2019; ISBN 978-1-83880-412-1 Available online: https://www.intechopen.com/chapters/69413 (accessed on 12 November 2022). [DOI: https://dx.doi.org/10.5772/intechopen.88684]
26. Azmir, J.; Zaidul, I.S.M.; Rahman, M.M.; Sharif, K.M.; Mohamed, A.; Sahena, F.; Jahurul, M.H.A.; Ghafoor, K.; Norulaini, N.A.N.; Omar, A.K.M. Techniques for extraction of bioactive compounds from plant materials: A review. J. Food Eng.; 2013; 117, pp. 426-436. [DOI: https://dx.doi.org/10.1016/j.jfoodeng.2013.01.014]
27. Safdar, M.N.; Kausar, T.; Jabbar, S.; Mumtaz, A.; Ahad, K.; Saddozai, A.A. Extraction and quantification of polyphenols from kinnow (Citrus reticulate L.) peel using ultrasound and maceration techniques. J. Food Drug Anal.; 2017; 25, pp. 488-500. [DOI: https://dx.doi.org/10.1016/j.jfda.2016.07.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28911634]
28. Gião, M.S.; González-Sanjosé, M.L.; Rivero-Pérez, M.D.; Pereira, C.I.; Pintado, M.E.; Malcata, F.X. Infusions of Portuguese medicinal plants: Dependence of Final Antioxidant Capacity and Phenol Content on Extraction Features. J. Sci. Food Agric.; 2007; 87, pp. 2638-2647. [DOI: https://dx.doi.org/10.1002/jsfa.3023] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20836172]
29. Saad, R.; Murugiah, G.; Abdulhamid, J.; Yusuf, E.; Fadli, M. Comparative Study between Percolation and Ultrasonication for the Extraction of Hibiscus and Jasmine Flowers Utilizing Antibacterial Bioassay. Int. J. Pharmacogn. Phytochem. Res.; 2014; 6, 6.
30. Kaneria, M.; Kanani, B.; Chanda, S. Assessment of effect of hydroalcoholic and decoction methods on extraction of antioxidants from selected Indian medicinal plants. Asian Pac. J. Trop. Biomed.; 2012; 2, pp. 195-202. [DOI: https://dx.doi.org/10.1016/S2221-1691(12)60041-0]
31. Barriada-Pereira, M.; Concha-Graña, E.; González-Castro, M.J.; Muniategui-Lorenzo, S.; López-Mahía, P.; Prada-Rodríguez, D.; Fernández-Fernández, E. Microwave-assisted extraction versus Soxhlet extraction in the analysis of 21 organochlorine pesticides in plants. J. Chromatogr. A; 2003; 1008, pp. 115-122. [DOI: https://dx.doi.org/10.1016/S0021-9673(03)01061-6]
32. Lucchesi, M.E.; Chemat, F.; Smadja, J. Solvent-free microwave extraction of essential oil from aromatic herbs: Comparison with conventional hydro-distillation—ScienceDirect. Available online: https://www.sciencedirect.com/science/article/pii/S0021967304008672?casa_token=NNufqmRkAr4AAAAA:eQ5216C1rLAbrOyNoPY_7UqZ5jIFviE8k3WKNyHdQBS-izFkmFT8jC5CUvBZ_x6NeP1WGpxZIY-X (accessed on 14 November 2022).
33. Lang, Q.; Wai, C.M. Supercritical fluid extraction in herbal and natural product studies—A practical review. Talanta; 2001; 53, pp. 771-782. [DOI: https://dx.doi.org/10.1016/S0039-9140(00)00557-9]
34. Chan, C.-H.; Yusoff, R.; Ngoh, G.-C.; Kung, F.W.-L. Microwave-assisted extractions of active ingredients from plants. J. Chromatogr. A; 2011; 1218, pp. 6213-6225. [DOI: https://dx.doi.org/10.1016/j.chroma.2011.07.040]
35. Chemat, F.; Rombaut, N.; Sicaire, A.-G.; Meullemiestre, A.; Fabiano-Tixier, A.-S.; Abert-Vian, M. Ultrasound assisted extraction of food and natural products. Mechanisms, techniques, combinations, protocols and applications. A review. Ultrason. Sonochem.; 2017; 34, pp. 540-560. [DOI: https://dx.doi.org/10.1016/j.ultsonch.2016.06.035]
36. Hammed, A.M.; Jaswir, I.; Amid, A.; Alam, Z.; Asiyanbi-H, T.T.; Ramli, N. Enzymatic Hydrolysis of Plants and Algae for Extraction of Bioactive Compounds. Food Rev. Int.; 2013; 29, pp. 352-370. [DOI: https://dx.doi.org/10.1080/87559129.2013.818012]
37. NN Azwanida A Review on the Extraction Methods Use in Medicinal Plants, Principle, Strength and Limitation. Med. Aromat. Plants; 2015; 4, 1000196.Available online: http://www.omicsgroup.org/journals/a-review-on-the-extraction-methods-use-in-medicinal-plants-principle-strength-and-limitation-2167-0412-1000196.php?aid=58448 (accessed on 12 July 2021).
38. trs1010_annex1.pdf. Available online: https://www.who.int/traditional-complementary-integrative-medicine/publications/trs1010_annex1.pdf (accessed on 29 July 2021).
39. Jones, W.P.; Kinghorn, A.D. Extraction of Plant Secondary Metabolites. Natural Products Isolation; Sarker, S.D.; Nahar, L. Methods in Molecular Biology Humana Press: Totowa, NJ, USA, 2012; 864, pp. 341-366. ISBN 978-1-61779-623-4 Available online: http://link.springer.com/10.1007/978-1-61779-624-1_13 (accessed on 29 July 2021).
40. Makanjuola, S.A. Influence of particle size and extraction solvent on antioxidant properties of extracts of tea, ginger, and tea–ginger blend. Food Sci. Nutr.; 2017; 5, pp. 1179-1185. [DOI: https://dx.doi.org/10.1002/fsn3.509]
41. Abubakar, A.R.; Haque, M. Preparation of Medicinal Plants: Basic Extraction and Fractionation Procedures for Experimental Purposes. J. Pharm. Bioallied Sci.; 2020; 12, 1. [DOI: https://dx.doi.org/10.4103/jpbs.JPBS_175_19]
42. Saha, A.; Pawar, V.M.; Jayaraman, S. Characterisation of Polyphenols in Terminalia arjuna Bark Extract. Indian J. Pharm. Sci.; 2012; 74, pp. 339-347. [DOI: https://dx.doi.org/10.4103/0250-474X.107067]
43. Mandal, S.; Patra, A.; Samanta, A.; Roy, S.; Mandal, A.; Mahapatra, T.D.; Pradhan, S.; Das, K.; Nandi, D.K. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. Asian Pac. J. Trop. Biomed.; 2013; 3, pp. 960-966. [DOI: https://dx.doi.org/10.1016/S2221-1691(13)60186-0]
44. Meena, D.K.; Sahoo, A.K.; Srivastava, P.P.; Sahu, N.P.; Jadhav, M.; Gandhi, M.; Swain, H.S.; Borah, S.; Das, B.K. On valorization of solvent extracts of Terminalia arjuna (arjuna) upon DNA scission and free radical scavenging improves coupling responses and cognitive functions under in vitro conditions. Sci. Rep.; 2021; 11, 10656. [DOI: https://dx.doi.org/10.1038/s41598-021-88710-w]
45. Akhter, S.; Hossain, M.; Haque, A.; Shahriar, M.; Bhuiyan, M. Phytochemical Screening, Antibacterial, Antioxidant and Cytotoxic Activity of the Bark Extract of Terminalia Arjuna. Eur. J. Sci. Res.; 2012; 86, pp. 543-552.
46. Yallappa, S.; Manjanna, J.; Sindhe, M.A.; Satyanarayan, N.D.; Pramod, S.N.; Nagaraja, K. Microwave assisted rapid synthesis and biological evaluation of stable copper nanoparticles using T. arjuna bark extract. Spectrochim. Acta A Mol. Biomol. Spectrosc.; 2013; 110, pp. 108-115. [DOI: https://dx.doi.org/10.1016/j.saa.2013.03.005]
47. Kumar, V.; Sharma, N.; Sourirajan, A.; Khosla, P.K.; Dev, K. Comparative evaluation of antimicrobial and antioxidant potential of ethanolic extract and its fractions of bark and leaves of Terminalia arjuna from north-western Himalayas, India. J. Tradit. Complement. Med.; 2017; 8, pp. 100-106. [DOI: https://dx.doi.org/10.1016/j.jtcme.2017.04.002]
48. Khatkar, S.; Nanda, A.; Ansari, S.H. Improved Methods of Extraction and In Vitro Evaluation of Antimicrobial Potential of Stem Bark of Terminalia arjuna. Curr. Biochem. Eng.; 2019; 5, pp. 50-56. [DOI: https://dx.doi.org/10.2174/2212711906666190131151937]
49. Filipiak-Szok, A.; Kurzawa, M.; Szłyk, E. Simultaneous Determination of Isoquinoline Alkaloids in Medicinal Asiatic Plants by Ultrasound-Assisted Extraction and High-Performance Liquid Chromatography—Mass Spectrometry with Principal Component Analysis. Anal. Lett.; 2018; 51, pp. 2575-2585. [DOI: https://dx.doi.org/10.1080/00032719.2018.1439050]
50. Oberoi, L.; Akiyama, T.; Lee, K.-H.; Liu, S.J. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine; 2011; 18, pp. 259-265. [DOI: https://dx.doi.org/10.1016/j.phymed.2010.07.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21315570]
51. Bachaya, H.A.; Iqbal, Z.; Khan, M.N.; Jabbar, A.; Gilani, A.H.; Din, I. In vitro and in vivo anthelmintic activity of terminalia arjuna bark. Int. J. Agric. Biol.; 2009; 11, 273.
52. Sayyad, S.F. Liquisolid Compacts: An Approach to Enhance the Dissolution Rate of Nimesulide. J. Appl. Pharm. Sci.; 2012; 2, pp. 115-121. Available online: http://www.japsonline.com/vol-2-issue-5/122-124.pdf (accessed on 28 May 2012). [DOI: https://dx.doi.org/10.7324/JAPS.2012.2521]
53. Barman, S.; Das, S. Hypoglycemic effect of ethanolic extract of bark of Terminalia arjuna Linn. in normal and alloxan-induced noninsulin-dependent diabetes mellitus albino rats. Int. J. Green Pharm.; 2012; 6, 279. [DOI: https://dx.doi.org/10.4103/0973-8258.108207]
54. Kumar, S.; Enjamoori, R.; Jaiswal, A.; Ray, R.; Seth, S.; Maulik, S.K. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J. Pharm. Pharmacol.; 2009; 61, pp. 1529-1536. [DOI: https://dx.doi.org/10.1211/jpp/61.11.0013]
55. Meghwani, H.; Prabhakar, P.; Mohammed, S.A.; Seth, S.; Hote, M.P.; Banerjee, S.K.; Arava, S.; Ray, R.; Maulik, S.K. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension. J. Ethnopharmacol.; 2017; 197, pp. 184-194. [DOI: https://dx.doi.org/10.1016/j.jep.2016.07.029]
56. Parashar, R. Study on Osteopotential activity of Terminalia arjuna bark extract using UMR 106 cells. J. Pharmacogn. Phytochem.; 2020; 9, pp. 1690-1693.
57. Uthirapathy, S. Novel Biomarkers of Atherogenic Diet Induced Dyslipidemia and Metabolic Syndrome Suppressed By Terminalia arjuna. Int. J. Pharma. Sci. Res.; 2019; 10, pp. 2528-2536. [DOI: https://dx.doi.org/10.13040/IJPSR.0975-8232.10(5).2528-36]
58. Mojarrad, S. Responses of liver and renal function markers against arjuna tree extract in induced Hyperlipidemia Rats. Issue S; 2020; 10, 6.
59. Gupta, A.; Chaphalkar, S.R. Inhibition of antigen specific t cell population. J. Immunol.; 2002; 169, pp. 802-808.
60. Pankaj, P.; Khamrui, K.; Devaraja, H.C.; Singh, R.R.B. The effects of alcoholic extract of Arjuna (Terminalia arjuna Wight & Arn.) bark on stability of clarified butterfat. J. Med. Plants Res.; 2013; 4, pp. 2545-2550.
61. Jahan, N.; Ali, S.; Asi, M.R.; Akhtar, A. Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits. Pak. Vet. J.; 2012; 32, 5.
62. Sivalokanathan, S.; Vijayababu, M.R.; Balasubramanian, M.P. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J. Gastroenterol. WJG; 2006; 12, pp. 1018-1024. [DOI: https://dx.doi.org/10.3748/wjg.v12.i7.1018]
63. Singh, G.; Singh, A.T.; Abraham, A.; Bhat, B.; Mukherjee, A.; Verma, R.; Agarwal, S.K.; Jha, S.; Mukherjee, R.; Burman, A.C. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J. Ethnopharmacol.; 2008; 117, pp. 123-129. [DOI: https://dx.doi.org/10.1016/j.jep.2008.01.022]
64. Mohammad, S.; Sadika, A.; Md, I.H.; Md, A.H.; Mohiuddin, A.B. Evaluation of in vitro antioxidant activity of bark extracts of Terminalia arjuna. J. Med. Plants Res.; 2012; 6, pp. 5286-5298. [DOI: https://dx.doi.org/10.5897/JMPR12.580]
65. Meena, D.; Sahoo, A.; Chowdhury, H.; Swain, H.S.; Sahu, N.; Behera, B.K.; Srivastava, P.; Das, B. Effects of extraction methods and solvent systems on extract yield, proximate composition and mineral profiling of Terminalia arjuna (Arjuna) dry powders and solvent extracts. J. Innovat. Pharmaceut. Biol. Sci.; 2020; 7, pp. 22-31.
66. Zujko, M.E.; Witkowska, A.M. Antioxidant Potential and Polyphenol Content of Selected Food. Int. J. Food Prop.; 2011; 14, pp. 300-308. [DOI: https://dx.doi.org/10.1080/10942910903176584]
67. Pandey, D.K.; Kaur, P. Optimization of extraction parameters of pentacyclic triterpenoids from Swertia chirata stem using response surface methodology. 3 Biotech; 2018; 8, 152. [DOI: https://dx.doi.org/10.1007/s13205-018-1174-6]
68. Marica Bakovic, N.H. Biologically Active Triterpenoids and Their Cardioprotective and Anti-Inflammatory Effects. J. Bioanal. Biomed.; 2015; 12, Available online: https://www.omicsonline.org/open-access/biologically-active-triterpenoids-and-their-cardioprotective-and-antiinflammatory-effects-1948-593X-S12-005.php?aid=53322 (accessed on 25 November 2021). [DOI: https://dx.doi.org/10.4172/1948-593X.S12-005]
69. Wang, W.; Ali, Z.; Shen, Y.; Li, X.C.; Khan, I.A. Ursane triterpenoids from the bark of Terminalia arjuna—ScienceDirect. Available online: https://www.sciencedirect.com/science/article/abs/pii/S0367326X10000109 (accessed on 25 November 2021).
70. Ríos, J.L.; Recio, M.C.; Maáñez, S.; Giner, R.M. Natural Triterpenoids as Anti-Inflammatory Agents. Studies in Natural Products Chemistry; Atta-ur-Rahman,
71. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev.; 2010; 4, pp. 118-126. [DOI: https://dx.doi.org/10.4103/0973-7847.70902] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22228951]
72. Chatha, S.A.S. Bioactive Components and Antioxidant Properties of Terminalia arjuna L. Extracts. J. Food Process. Technol.; 2014; 5, 1. [DOI: https://dx.doi.org/10.4172/2157-7110.1000298]
73. Papuc, C.; Goran, G.V.; Predescu, C.N.; Nicorescu, V.; Stefan, G. Plant Polyphenols as Antioxidant and Antibacterial Agents for Shelf-Life Extension of Meat and Meat Products: Classification, Structures, Sources, and Action Mechanisms: Polyphenols extending meat shelf-life. Compr. Rev. Food Sci. Food Saf.; 2017; 16, pp. 1243-1268. [DOI: https://dx.doi.org/10.1111/1541-4337.12298] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33371586]
74. Zhang, Y.-J.; Gan, R.-Y.; Li, S.; Zhou, Y.; Li, A.-N.; Xu, D.-P.; Li, H.-B. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules; 2015; 20, pp. 21138-21156. [DOI: https://dx.doi.org/10.3390/molecules201219753]
75. Ghadigaonkar, S.; Reddy, A.G.; Kalakumar, B.; Anilkumar, B. Screening of antioxidant and free radical scavenging activities of Terminalia arjuna Roxb. Pharma Innov. J.; 2021; 10, pp. 1-5.
76. Medicinal Plants with Anti-Inflammatory Activities from Selected Countries and Regions of Africa. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086115/ (accessed on 11 July 2021).
77. Halder, S.; Bharal, N.; Mediratta, P.K.; Kaur, I.; Sharma, K.K. Anti-inflammatory, immunomodulatory and antinociceptive activity of Terminalia arjuna Roxb bark powder in mice and rats. Indian J. Exp. Biol.; 2009; 7, pp. 577-583.
78. Safayhi, H.; Sailer, E.-R. Anti-Inflammatory Actions of Pentacyclic Triterpenes. Planta Med.; 1997; 63, pp. 487-493. [DOI: https://dx.doi.org/10.1055/s-2006-957748]
79. Yasui, K.; Baba, A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm. Res.; 2006; 55, pp. 359-363. [DOI: https://dx.doi.org/10.1007/s00011-006-5195-y]
80. Shah, S.M.A.; Akram, M.; Riaz, M.; Munir, N.; Rasool, G. Cardioprotective Potential of Plant-Derived Molecules: A Scientific and Medicinal Approach. Dose-Response; 2019; 17, 1559325819852243. [DOI: https://dx.doi.org/10.1177/1559325819852243]
81. Khaliq, F.; Fahim, M. Role of Terminalia Arjuna in Improving Cardiovascular Functions: A Review. Indian J. Physiol. Pharmacol.; 2018; 62, pp. 8-19.
82. Alique, M.; Luna, C.; Carracedo, J.; Ramírez, R. LDL biochemical modifications: A link between atherosclerosis and aging. Food Nutr. Res.; 2015; 59, 29240. [DOI: https://dx.doi.org/10.3402/fnr.v59.29240]
83. Parveen, A.; Babbar, R.; Agarwal, S.; Kotwani, A.; Fahim, M. Mechanistic Clues in the Cardioprotective Effect of Terminalia Arjuna Bark Extract in Isoproterenol-Induced Chronic Heart Failure in Rats. Cardiovasc. Toxicol.; 2011; 11, pp. 48-57. [DOI: https://dx.doi.org/10.1007/s12012-010-9099-2]
84. Pawar, R.S.; Bhutani, K.K. Effect of oleanane triterpenoids from Terminalia arjuna—a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine; 2005; 12, pp. 391-393. [DOI: https://dx.doi.org/10.1016/j.phymed.2003.11.007]
85. Gholipour, S.; Sewell, R.; Lorigooini, Z.; Rafieian-kopaei, M. Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects. Curr. Pharm. Des.; 2018; 24, pp. 3123-3131. [DOI: https://dx.doi.org/10.2174/1381612824666180911121525]
86. Nwodo, N.J.; Nnadi, C.O.; Ibezim, A.; Mbah, C.J. Plants with Hypolipidaemic Effects from Nigerian Flora; IntechOpen: London, UK, 2014; ISBN 978-953-51-1215-0 Available online: https://www.intechopen.com/chapters/45882 (accessed on 2 November 2022). [DOI: https://dx.doi.org/10.5772/57181]
87. Alam, M.M.; Haque, A.; Begum, R. Anti-hyperglycemic and lipid lowering effect of Terminalia arjuna Bark extract on Streptozotocin induced Type-2 Diabetic Model Rats. Int. J. Pharm. Pharm. Sci.; 2011; 3, pp. 449-453.
88. Bhat, O.; Kumar, P.; Rao, K.; Ahmad, A.; Dhawan, V. Terminalia arjuna prevents Interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ-mediated pathway in Apo E-/- mice. Inflammopharmacology; 2018; 26, pp. 583-598. [DOI: https://dx.doi.org/10.1007/s10787-017-0357-9]
89. Greenwell, M.; Rahman, P.K.S.M. Medicinal Plants: Their Use in Anticancer Treatment. Int. J. Pharm. Sci. Res.; 2015; 6, pp. 4103-4112. [DOI: https://dx.doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12]
90. Gangadevi, V.; Muthumary, J. Taxol production by Pestalotiopsis terminaliae, an endophytic fungus of Terminalia arjuna (arjun tree). Biotechnol. Appl. Biochem.; 2009; 52, pp. 9-15. [DOI: https://dx.doi.org/10.1042/BA20070243]
91. Runowicz, C.D.; Wiernik, P.H.; Einzig, A.I.; Goldberg, G.L.; Horwitz, S.B. Taxol in ovarian cancer. Cancer; 1993; 71, pp. 1591-1596. [DOI: https://dx.doi.org/10.1002/cncr.2820710442]
92. Parker, A.L.; Kavallaris, M.; McCarroll, J.A. Microtubules and Their Role in Cellular Stress in Cancer. Front. Oncol.; 2014; 4, 153. [DOI: https://dx.doi.org/10.3389/fonc.2014.00153] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24995158]
93. Singh, S.; Verma, S.K.; Kumar, S. Analysis of anti-cancer potential of Terminalia arjuna. Int. J. Adv. Sci. Res. Manag.; 2017; 2, pp. 82-87.
94. Anu Mary Ealia, S.; Saravanakumar, M.P. A review on the classification, characterisation, synthesis of nanoparticles and their application. IOP Conf. Ser. Mater. Sci. Eng.; 2017; 263, 032019. [DOI: https://dx.doi.org/10.1088/1757-899X/263/3/032019]
95. Parveen, K.; Banse, V.; Ledwani, L. Green synthesis of nanoparticles: Their advantages and disadvantages. AIP Conf. Proc.; 2016; 1724, 020048. [DOI: https://dx.doi.org/10.1063/1.4945168]
96. Salah, N.; Habib, S.S.; Khan, Z.H.; Memic, A.; Azam, A.; Alarfaj, E.; Zahed, N.; Al-Hamedi, S. High-energy ball milling technique for ZnO nanoparticles as antibacterial material. Int. J. Nanomed.; 2011; 6, pp. 863-869. [DOI: https://dx.doi.org/10.2147/IJN.S18267]
97. Li, Z. Synthesis and Characterization of Carbon-Encapsulated Magnetic Nanoparticles via Arc-Plasma Assisted CVD. J. Nanosci. Nanotechnol.; 2009; 9, 1757.Available online: http://www.ingentaconnect.com/content/asp/jnn/2009/00000009/00000012/art00133 (accessed on 12 November 2022). [DOI: https://dx.doi.org/10.1166/jnn.2009.1757]
98. Wang, W.-N.; Lenggoro, I.W.; Terashi, Y.; Kim, T.O.; Okuyama, K. One-step synthesis of titanium oxide nanoparticles by spray pyrolysis of organic precursors. Mater. Sci. Eng. B; 2005; 123, pp. 194-202. [DOI: https://dx.doi.org/10.1016/j.mseb.2005.08.006]
99. Hatakeyama, Y.; Judai, K.; Onishi, K.; Takahashi, S.; Kimura, S.; Nishikawa, K. Anion and cation effects on the size control of Au nanoparticles prepared by sputter deposition in imidazolium-based ionic liquids. Phys. Chem. Chem. Phys.; 2016; 18, pp. 2339-2349. [DOI: https://dx.doi.org/10.1039/C5CP04123F]
100. Paul, S. Nanomaterials synthesis by electrodeposition techniques for high-energetic electrodes in fuel cell. Nanomater. Energy; 2015; 4, pp. 80-89. [DOI: https://dx.doi.org/10.1680/nme.14.00031]
101. Pradeep, A.; Priyadharsini, P.; Chandrasekaran, G. Sol–gel route of synthesis of nanoparticles of MgFe2O4 and XRD, FTIR and VSM study. J. Magn. Magn. Mater.; 2008; 320, pp. 2774-2779. [DOI: https://dx.doi.org/10.1016/j.jmmm.2008.06.012]
102. Patiño-Ruiz, D.A.; Meramo-Hurtado, S.I.; González-Delgado, Á.D.; Herrera, A. Environmental Sustainability Evaluation of Iron Oxide Nanoparticles Synthesized via Green Synthesis and the Coprecipitation Method: A Comparative Life Cycle Assessment Study. ACS Omega; 2021; 6, pp. 12410-12423. [DOI: https://dx.doi.org/10.1021/acsomega.0c05246]
103. Ying, S.; Guan, Z.; Ofoegbu, P.C.; Clubb, P.; Rico, C.; He, F.; Hong, J. Green synthesis of nanoparticles: Current developments and limitations. Environ. Technol. Innov.; 2022; 26, 102336. [DOI: https://dx.doi.org/10.1016/j.eti.2022.102336]
104. Govindaraju, K.; Basha, S.K.; Kumar, V.G.; Singaravelu, G. Silver, gold and bimetallic nanoparticles production using single-cell protein (Spirulina platensis) Geitler. J. Mater. Sci.; 2008; 43, pp. 5115-5122. [DOI: https://dx.doi.org/10.1007/s10853-008-2745-4]
105. Omajali, J.B.; Mikheenko, I.P.; Merroun, M.L.; Wood, J.; Macaskie, L.E. Characterization of intracellular palladium nanoparticles synthesized by Desulfovibrio desulfuricans and Bacillus benzeovorans. J. Nanoparticle Res.; 2015; 17, 264. [DOI: https://dx.doi.org/10.1007/s11051-015-3067-5]
106. Saratale, R.G.; Karuppusamy, I.; Saratale, G.D.; Pugazhendhi, A.; Kumar, G.; Park, Y.; Ghodake, G.S.; Bharagava, R.N.; Banu, J.R.; Shin, H.S. A comprehensive review on green nanomaterials using biological systems: Recent perception and their future applications. Colloids Surf. B Biointerfaces; 2018; 170, pp. 20-35. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2018.05.045]
107. Ijaz, I.; Gilani, E.; Nazir, A.; Bukhari, A. Detail review on chemical, physical and green synthesis, classification, characterizations and applications of nanoparticles. Green Chem. Lett. Rev.; 2020; 13, pp. 223-245. [DOI: https://dx.doi.org/10.1080/17518253.2020.1802517]
108. Singh, J.; Kumar, S.; Rathi, B.; Bhrara, K.; Chhikara, B.S. Therapeutic analysis of Terminalia arjuna plant extracts in combinations with different metal nanoparticles. J. Mater. Nanosci.; 2015; 2, pp. 1-7.
109. Zafar, F.; Jahan, N.; Khalil-Ur-Rahman,; Asi, M.R.; Zafar, W.-U.-I. Nanosuspension enhances dissolution rate and oral bioavailability of Terminalia arjuna bark extract in vivo and in vitro. Asian Pac. J. Trop. Biomed.; 2020; 10, 164. [DOI: https://dx.doi.org/10.4103/2221-1691.280293]
110. Mousumi, M.; Amit, B.; Gouriprasad, D.; Dilip, K.N. Nephroprotective Effect of Green Synthesised Gold Nanoparticles Using Bark Extract of Terminalia Arjuna on Acetaminophen Induced Nephrotoxicity in Male Albino Rat. Int. J. Pharma. Bio. Sci.; 2020; 10, Available online: https://www.ijlpr.com/abstract1.php?aid=602 (accessed on 7 July 2021). [DOI: https://dx.doi.org/10.22376/ijpbs/lpr.2020.10.4.P22-30]
111. Saha, R.; Subramani, K.; Balu, K.; Suriyaprabha, R.; Siva, P.; Venkatachalam, R. Influence of the various synthesis methods on the ZnO nanoparticles property made using the bark extract of Terminalia arjuna. Mater. Chem. Phys.; 2018; 209, pp. 208-216. [DOI: https://dx.doi.org/10.1016/j.matchemphys.2018.01.023]
112. Mitra, M.; Laha, J.; Nandi, D.K. Effective Role of Terminalia arjuna Reduced Gold Nanoparticles on Reproductive Dysfunction Induced by Acetaminophen in Male Wistar Rat. BioNanoScience; 2020; 10, pp. 942-949. [DOI: https://dx.doi.org/10.1007/s12668-020-00737-x]
113. Sudarsan, S.; Kumar Shankar, M.; Kumar Belagal Motatis, A.; Shankar, S.; Krishnappa, D.; Mohan, C.D.; Rangappa, K.S.; Gupta, V.K.; Siddaiah, C.N. Green Synthesis of Silver Nanoparticles by Cytobacillus firmus Isolated from the Stem Bark of Terminalia arjuna and Their Antimicrobial Activity. Biomolecules; 2021; 11, 259. [DOI: https://dx.doi.org/10.3390/biom11020259]
114. Ahmed, Q.; Gupta, N.; Kumar, A.; Nimesh, S. Antibacterial efficacy of silver nanoparticles synthesized employing Terminalia arjuna bark extract. Artif. Cells Nanomed. Biotechnol.; 2017; 45, pp. 1192-1200. [DOI: https://dx.doi.org/10.1080/21691401.2016.1215328]
115. Amini, S.M.; Akbari, A. Metal nanoparticles synthesis through natural phenolic acids. IET Nanobiotechnol.; 2019; 13, pp. 771-777. [DOI: https://dx.doi.org/10.1049/iet-nbt.2018.5386]
116. Dwivedi, P.; Narvi, S.S.; Tewari, R.P. Phytofabrication characterization and comparative analysis of Ag nanoparticles by diverse biochemicals from Elaeocarpus ganitrus Roxb., Terminalia arjuna Roxb., Pseudotsuga menzietii, Prosopis spicigera, Ficus religiosa, Ocimum sanctum, Curcuma longa. Ind. Crops Prod.; 2014; 54, pp. 22-31. [DOI: https://dx.doi.org/10.1016/j.indcrop.2013.12.050]
117. Amina, S.J.; Guo, B. A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle. Int. J. Nanomed.; 2020; 15, pp. 9823-9857. [DOI: https://dx.doi.org/10.2147/IJN.S279094] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33324054]
118. Garibo, D.; Borbón-Nuñez, H.A.; de León, J.N.D.; García Mendoza, E.; Estrada, I.; Toledano-Magaña, Y.; Tiznado, H.; Ovalle-Marroquin, M.; Soto-Ramos, A.G.; Blanco, A. et al. Green synthesis of silver nanoparticles using Lysiloma acapulcensis exhibit high-antimicrobial activity. Sci. Rep.; 2020; 10, 12805. [DOI: https://dx.doi.org/10.1038/s41598-020-69606-7] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32732959]
119. Bag, B. Terminalia Arjuna Bark Extract Mediated Size Controlled Synthesis of Polyshaped Gold Nanoparticles and Its Application in Catalysis. Int. J. Res. Chem. Environ.; 2012; 2, pp. 338-344.
120. Suganthy, N.; Sri Ramkumar, V.; Pugazhendhi, A.; Benelli, G.; Archunan, G. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: Assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res.; 2018; 25, pp. 10418-10433. [DOI: https://dx.doi.org/10.1007/s11356-017-9789-4]
121. Saiqa Ikram, S.A. Silver Nanoparticles: One Pot Green Synthesis Using Terminalia arjuna Extract for Biological Application. J. Nanomedicine Nanotechnol.; 2015; 6, 1000309.Available online: https://www.omicsonline.org/open-access/silver-nanoparticles-one-pot-green-synthesis-using-terminalia-arjuna-extract-for-biological-application-2157-7439-1000309.php?aid=56647 (accessed on 6 July 2021). [DOI: https://dx.doi.org/10.4172/2157-7439.1000309]
122. Prasannaraj, G.; Sahi, S.V.; Ravikumar, S.; Venkatachalam, P. Enhanced Cytotoxicity of Biomolecules Loaded Metallic Silver Nanoparticles Against Human Liver (HepG2) and Prostate (PC3) Cancer Cell Lines. J. Nanosci. Nanotechnol.; 2016; 16, pp. 4948-4959. [DOI: https://dx.doi.org/10.1166/jnn.2016.12336]
123. Yallappa, S.; Manjanna, J. Biological Evaluation of Silver Nanoparticles Obtained from T. arjuna Bark Extract as Both Reducing and Capping Agent. J. Clust. Sci.; 2014; 25, pp. 1449-1462. [DOI: https://dx.doi.org/10.1007/s10876-014-0722-4]
124. Dwivedi, P.; Narvi, S.; Tewari, R. Overwhelming Antibacterial Activity by Terminalia arjuna Aided Herbal Ag/CS-PVC: Nanocomposite for Overcoming Biomaterials Associated Infections. Adv. Sci.; 2015; 7, 1651. [DOI: https://dx.doi.org/10.1166/asem.2015.1651]
125. Mendeley Reference Manager. Available online: https://www.mendeley.com/reference-manager/reader/b5ebf52d-329c-328e-b600-03bb109da9a2/73013400-fb1e-17dd-1794-d9530d74df29 (accessed on 6 July 2021).
126. Yallappa, S.; Manjanna, J.; Dhananjaya, B.L.; Vishwanatha, U.; Ravishankar, B.; Gururaj, H.; Niranjana, P.; Hungund, B.S. Phytochemically Functionalized Cu and Ag Nanoparticles Embedded in MWCNTs for Enhanced Antimicrobial and Anticancer Properties. Nano-Micro Lett.; 2016; 8, pp. 120-130. [DOI: https://dx.doi.org/10.1007/s40820-015-0066-0]
127. Lachmapure, M.; Paralikar, P.; Palanisamy, M.; Alves, M.; Rai, M. Efficacy of biogenic silver nanoparticles against clinical isolates of fungi causing mycotic keratitis in humans. IET Nanobiotechnol.; 2017; 11, pp. 809-814. [DOI: https://dx.doi.org/10.1049/iet-nbt.2017.0003]
128. Koparde, S.; Gaikwad, D. Antibacterial potential of green silver nanoparticles synthesized from medicinal plant terminalia arjuna. Int. J. Res. Biosci. Agric. Technol.; 2017; 5, pp. 258-260.
129. Akther, T.; Priya, S.; Sah, S.K.; Khan, M.S.; Hemalatha, S. Ta-AgNps are potential antimicrobial resistance breakers. J. Nanostructures; 2019; 9, pp. 376-383. [DOI: https://dx.doi.org/10.22052/JNS.2019.02.019]
130. Bag, B.G.; Majumdar, R. Vesicular self-assembly of a natural triterpenoid arjunolic acid in aqueous medium: Study of entrapment properties and in situ generation of gel-gold nanoparticle hybrid material. RSC Adv.; 2014; 4, pp. 53327-53334. [DOI: https://dx.doi.org/10.1039/C4RA08710K]
131. Mitra, M.; Bandyopadhyay, A.; Datta, G.; Nandi, D.K. Effective Dose of Herbal Gold Nanoparticles for Protection of Acetaminophen-Induced Hepatotoxicity in Male Albino Rats. BioNanoScience; 2020; 10, pp. 1094-1106. [DOI: https://dx.doi.org/10.1007/s12668-020-00766-6]
132. Gopinath, K.; Venkatesh, K.S.; Ilangovan, R.; Sankaranarayanan, K.; Arumugam, A. Green synthesis of gold nanoparticles from leaf extract of Terminalia arjuna, for the enhanced mitotic cell division and pollen germination activity. Ind. Crops Prod.; 2013; 50, pp. 737-742. [DOI: https://dx.doi.org/10.1016/j.indcrop.2013.08.060]
133. Mitra, M.; Bandyopadhyay, A.; Datta, G.; Nandi, D. Protective Role of Green Synthesized Gold Nanoparticles Using Terminalia arjuna against Acetaminophen Induced Hematological Alterations in Male Wistar Rats. J. Nanomed. Nanotechnol.; 2019; 10, [DOI: https://dx.doi.org/10.35248/2157-7439.19.10.530]
134. Dudhane, A.A.; Waghmode, S.R.; Dama, L.B.; Sonawane, A.; Katariya, S. Synthesis and Characterization of Gold Nanoparticles using Plant Extract of Terminalia arjuna with Antibacterial Activity. J. Nanosci. Nanotechnol.; 2019; 15, pp. 75-82.
135. Anuradha, V.; Shankar, P.; Bhuvana, P.; SyedAli, M.; Yogananth, N. Terminalia Arjuna Bark Assisted Biosynthesis, Characterization and Bioactivity of Metal oxide Nanoparticles. J. Chem. Pharm. Res.; 2017; 9, pp. 34-46.
136. Kangralkar, M.V.; Manjanna, J. Manjanna, Green Synthesis of iron nanoparticles by Terminalia arjuna bark extract and photodegradation of rose Bengal. Iran. J. Catal.; 2020; 8, pp. 181-188.
137. Garai, C.; Hasan, S.N.; Barai, A.C.; Ghorai, S.; Panja, S.K.; Bag, B.G. Green synthesis of Terminalia arjuna-conjugated palladium nanoparticles (TA-PdNPs) and its catalytic applications. J. Nanostructure Chem.; 2018; 8, pp. 465-472. [DOI: https://dx.doi.org/10.1007/s40097-018-0288-z]
138. Gaikwad, D.; Jadhav, N. Terminalia arjuna transdermal matrix formulation containing different polymer components. Asian J. Pharm. Clin. Res.; 2019; 12, pp. 266-270. [DOI: https://dx.doi.org/10.22159/ajpcr.2019.v12i6.32643]
139. Shrivastava, V.P.; Subedi, D.P. Surface Modification of Polymeric Biomaterials by Coating Herbal Extracts. J. Nano Res. Adv. Mater. Polym. Sci.; 2020; 1, 2.
140. Gaikwad, D.; Jadhav, N. Formulation design and evaluation of an emulgel containing Terminalia arjuna bark extract for transdermal delivery. Pharmacogn. Mag.; 2018; 14, 249. [DOI: https://dx.doi.org/10.4103/pm.pm_578_17]
141. Noreen, S.; Ghumman, S.A.; Batool, F.; Ijaz, B.; Basharat, M.; Noureen, S.; Kausar, T.; Iqbal, S. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery. Int. J. Biol. Macromol.; 2020; 152, pp. 1056-1067. [DOI: https://dx.doi.org/10.1016/j.ijbiomac.2019.10.193]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Herbal medicines were the main source of therapeutic agents in the ancestral era. Terminalia arjuna (TA) is one such medicinal plant widely known for its several medicinal properties, especially its cardiovascular properties. They have several phytochemicals, such as flavonoids, polyphenols, triterpenoids, tannins, glycosides, and several minerals, proteins, and others that are responsible for the above-mentioned medicinal properties. In this review, we have first elaborated on the various processes and their parameters for the efficient extraction of relevant phytochemicals from TA extracts. Secondly, the mechanisms behind the various medicinal properties of TA extracts are explained. We have also highlighted the role of TA extracts on the green synthesis of metallic nanoparticles, especially silver and gold nanoparticles, with an elucidation on the mechanisms behind the synthesis of nanoparticles. Finally, TA extracts-based polymeric formulations are discussed with limitations and future perspectives. We believe that this review could help researchers understand the importance of a well-known cardioprotective medicinal plant, TA, and its biomedical properties, as well as their role in green nanotechnology and various formulations explored for encapsulating them. This review will help researchers design better and greener nanomedicines as well as better formulations to improve the stability and bioavailability of TA extracts.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632-014, India; Centre for Biomaterials, Cellular and Molecular Theranostics, Vellore Institute of Technology, Vellore 632-014, India
2 Centre for Biomaterials, Cellular and Molecular Theranostics, Vellore Institute of Technology, Vellore 632-014, India